Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

Document › Details

Bayer AG. (2/4/22). "Press Release: Bayer Will Discontinue Phase II Development Candidate eliapixant [only for specialized press]". Berlin.

	Organisation	Evotec SE (FSE: EVT, MDA X/TecDAX, Nasdaq: EVO)
	Group	Evotec (Group)
	Organisation 2	Bayer Pharma division
	Group	Bayer (Group)
	Product	eliapixant (BAY 1817080)
	Product 2	phase 2 study

Original document
accessed by [iito] on 2022-02-07

Record changed: 2022-02-07

More documents for Evotec (Group)

[1] Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg....
[2] IMIdomics, Inc.. (2/15/22). "Press Release: IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE". San Rafael, CA & Barcelona....
[3] Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg....
[4] Evotec SE. (1/25/22). "Press Release: Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology". Hamburg....
[5] Evotec SE. (1/3/22). "Press Release: Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic". Hamburg....
[6] Evotec SE. (12/16/21). "Press Release: Evotec Receives US$ 18 m Grant for Women’s Health". Hamburg....
[7] Evotec SE. (11/18/21). "Press Release: Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership". Hamburg & Cambridge, MA....
[8] Evotec SE. (11/16/21). "Press Release: Evotec Announces the Exercise of the Greenshoe Option". Hamburg....
[9] Evotec SE. (11/3/21). "Press Release: Evotec SE Announces Placement of Its Public Offering of American Depositary Shares". Hamburg....
[10] Evotec SE. (10/27/21). "Press Release: Translational BRIDGE beLAB2122 in Collaboration with Bristol Myers Squibb Identifies First Project". Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top